These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11355935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 5. [Antitumor drug screening at the National Cancer Institute, U.S.A].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2809-15. PubMed ID: 3310904
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
    Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
    [No Abstract] [Full Text] [Related]

  • 10. New initiatives aim to test more cancer drugs for children.
    Brower V.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1808-10. PubMed ID: 15601634
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP, Alberts DS.
    J Clin Oncol; 2005 May 20; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Screening at the National Cancer Institute.
    Goldin A, Venditti JM, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar 06; (45):37-48. PubMed ID: 337155
    [No Abstract] [Full Text] [Related]

  • 19. Mining the NCI screening database: explorations of agents involved in cell cycle regulation.
    Wallqvist A, Monks A, Rabow AA, Thanki N, Shoemaker RH, Covell DG.
    Prog Cell Cycle Res; 2003 Mar 06; 5():173-9. PubMed ID: 14593711
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.